Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Recalls? J&J CEO Gets A 55% Bonus Increase
Pharmalot
Monday, February 27, 2012 - 10:26am
tags:
William Weldon, executive pay, recalls, JNJ
Questcor Pharmaceuticals Beats Up on Analysts Yet Again
Motley Fool
Monday, February 27, 2012 - 10:25am
tags:
Questcor, earnings
ISTA Pharmaceuticals Misses on Revenues but Beats on EPS
Motley Fool
Monday, February 27, 2012 - 10:24am
tags:
ISTA Pharmaceuticals, earnings
Buffett says may consider selling J&J stock
Reuters
Monday, February 27, 2012 - 10:23am
tags:
JNJ, Warren Buffett
Auxilium Misses 4Q Estimates
Yahoo/Zacks
Monday, February 27, 2012 - 10:22am
tags:
Auxilium, earnings
China Biotech In Review: Newsummit To Stage $80 Million IPO On NYSE
Seeking Alpha
Monday, February 27, 2012 - 10:22am
tags:
China, IPOs, Newsummit Biopharma
GENFIT's drug candidate GFT505 gets patent protection from major countries
Pharmabiz
Saturday, February 25, 2012 - 10:02am
tags:
Genfit, GFT505, diabetes
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Genetic Engineering News
Saturday, February 25, 2012 - 9:50am
tags:
Forest Labs, Colobreathe
U.K. enjoys bargain-basement drug prices, report finds
Fierce Pharma
Saturday, February 25, 2012 - 9:47am
tags:
drug prices
FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease
PharmaLive
Saturday, February 25, 2012 - 9:43am
tags:
Impax Laboratories, Parkinson's Disease
Drug Companies Feel Price Pressure
PharmPro
Saturday, February 25, 2012 - 9:39am
tags:
drug pricing
1 Thing to Know Before Betting on the Next Blockbuster Drug
Motley Fool
Saturday, February 25, 2012 - 9:32am
tags:
New J&J CEO must fix sullied image, integrate Synthes
Yahoo/Reuters
Saturday, February 25, 2012 - 9:31am
tags:
JNJ, Synthes
BigPharma & Trust: Mostly Irrelevant
Motley Fool
Saturday, February 25, 2012 - 9:28am
tags:
Glenmark Generics recalling birth control pills
Yahoo/AP
Saturday, February 25, 2012 - 9:26am
tags:
Glenmark, generics, birth control, contraceptives
Warner Chilcott 4Q profit grows as charges fall
Yahoo/AP
Saturday, February 25, 2012 - 9:25am
tags:
Warner Chilcott
Biotech Investors, Take Note: Margin of Victory Matters
Motley Fool
Saturday, February 25, 2012 - 9:24am
tags:
Vivus's Qnexa And Its Potential Value
Seeking Alpha
Saturday, February 25, 2012 - 9:23am
tags:
Vivus, Qnexa, obesity, weight loss
Not Just Any Biotech Stock Will Do
Motley Fool
Saturday, February 25, 2012 - 9:20am
tags:
PDL Biopharma, Amgen, Threshold Pharmaceuticals
Theratechnologies: Update on Motion for Authorization to Institute Class Action Against the Company
Yahoo/MarketWire
Saturday, February 25, 2012 - 9:18am
tags:
Theratechnologies

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.